Finance and Cost-Effectiveness

Sub-topics

Find more specific references for the following sub-topic(s):

1. Economics and Cost-Effectiveness
2. Finance

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 1. Investing in Health
2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
3. 3. Strengthening Health Systems
4. 4. Priorities for Global Research and Development of Interventions
5. 5. Science and Technology for Disease Control: Past, Present, and Future
6. 6. Product Development Priorities
7. 7. Economic Approaches to Valuing Global Health Research
8. 8. Improving the Health of Populations: Lessons of Experience
9. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
10. 10. Gender Differentials in Health
11. 11. Fiscal Policies for Health Promotion and Disease Prevention
12. 12. Financing Health Systems in the 21st Century
13. 13. Recent Trends and Innovations in Development Assistance for Health
14. 14. Ethical Issues in Resource Allocation, Research, and New Product Development
15. 15. Cost–Effectiveness Analysis for Priority Setting
16. 16. Tuberculosis
17. 17. Sexually Transmitted Infections
18. 18. HIV/AIDS Prevention and Treatment
19. 19. Diarrheal Diseases
20. 20. Vaccine–Preventable Diseases
21. 21. Conquering Malaria
22. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
23. 23. Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis
24. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
25. 25. Acute Respiratory Infections in Children
26. 26. Maternal and Perinatal Conditions
27. 27. Newborn Survival
28. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
29. 29. Health Service Interventions for Cancer Control in Developing Countries
30. 30. Diabetes: The Pandemic and Potential Solutions
31. 31. Mental Disorders
32. 32. Neurological Disorders
33. 33. Cardiovascular Disease
34. 34. Inherited Disorders of Hemoglobin
35. 35. Respiratory Diseases of Adults
36. 36. Diseases of the Kidney and the Urinary System
37. 37. Skin Diseases
38. 38. Oral and Craniofacial Diseases and Disorders
39. 39. Unintentional Injuries
40. 40. Interpersonal Violence
41. 41. Water Supply, Sanitation, and Hygiene Promotion
42. 42. Indoor Air Pollution
43. 43. Air and Water Pollution: Burden and Strategies for Control
44. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
45. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
46. 46. Tobacco Addiction
47. 47. Alcohol
48. 48. Illicit Opiate Abuse
49. 49. Learning and Developmental Disabilities
50. 50. Loss of Vision and Hearing
51. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
52. 52. Pain Control for People with Cancer and AIDS
53. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
54. 54. Information to Improve Decision Making for Health
55. 55. Drug Resistance
56. 56. Community Health and Nutrition Programs
57. 57. Contraception
58. 58. School–Based Health and Nutrition Programs
59. 59. Adolescent Health Programs
60. 60. Occupational Health
61. 61. Natural Disaster Mitigation and Relief
62. 63. Integrated Management of the Sick Child
63. 64. General Primary Care
64. 65. The District Hospital
65. 66. Referral Hospitals
66. 67. Surgery
67. 68. Emergency Medical Services
68. 69. Complementary and Alternative Medicine
69. 70. Improving the Quality of Care in Developing Countries
70. 71. Health Workers: Building and Motivating the Workforce
71. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
72. 73. Strategic Management of Clinical Services

Global Burden of Disease and Risk Factors

1. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
2. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
3. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
4. 5. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates
5. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 2. Success in Addressing Priorities
3. 3. Cost–Effectiveness Analysis
4. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
5. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
6. 6. Providing Interventions
7. 7. Pillars of the Health System
8. 8. The Way Forward: A Blueprint for Action

Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Cost-effectiveness of Interventions for Childhood Conditions in Low- and Middle-Income Countries
2. Cost-effectiveness of Interventions for Epidemic Tuberculosis in Low- and Middle-Income Countries
3. Cost-effectiveness of Interventions for Endemic Tuberculosis in Low- and Middle-Income Countries
4. Cost-effectiveness of Interventions for Malaria in Sub-Saharan Africa
5. Efficiency of Interventions
6. Cost-effectiveness of Interventions for Diarrheal Disease in Low- and Middle-Income Countries
7. Cost-effectiveness of Interventions for Traffic Accidents in Low- and Middle-Income Countries
8. Cost-effectiveness of Interventions for Dengue and Hepatitis B in Low- and Middle-Income Countries
9. Cost-effectiveness of Interventions for Neurological Disorders in Low- and Middle-Income Countries
10. Cost-effectiveness of Interventions for Mental Disorders in Low- and Middle-Income Countries
11. Cost-effectiveness of Surgery and Emergency Medical Care in Low- and Middle-Income Countries
12. Cost-effectiveness of Interventions for Cardiovascular Disease and Diabetes in Low- and Middle-Income Countries
13. Cost-effectiveness of Interventions for Heart Attacks and Stroke in Low- and Middle-Income Countries
14. Cost-effectiveness of Interventions for Coronary Heart Disease in Low- and Middle-Income Countries
15. Cost-effectiveness of Interventions for Tobacco Addiction in Low- and Middle-Income Countries
16. Cost-effectiveness of Interventions for Alcohol Abuse in Low- and Middle-Income Countries
17. Cost-effectiveness of Interventions for HIV/AIDS Treatment in Low- and Middle-Income Countries
18. Cost-effectiveness of Interventions for HIV/AIDS Prevention in Low- and Middle-Income Countries

Chapter 01. Investing in Health

1. Health Expenditures, 2001, By Country Income Level
2. Reducing Under-five Mortality: How much health will a million dollars buy?
3. Preventing and Treating HIV/AIDS: How much health will a million dollars buy?
4. Preventing and Treating Noncommunicable Diseases: How much health will a million dollars buy?
5. Cervical Cancer and Surgically Treatable Conditions: How much health will a million dollars buy?

Chapter 20. Vaccine-Preventable Diseases

1. Cost per Deaths and Disability Adjusted Life Years Averted by Vaccination, 2001
2. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Region, 2001
3. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Immunization Strategy, 2001

Chapter 18. HIV/AIDS Prevention and Treatment

1. Cost-effectiveness of Voluntary Counseling and Testing for HIV/AIDS
2. Cost-effectiveness of Blood Safety Practices for HIV Prevention
3. Cost-effectiveness of Peer-based Programs for Preventing HIV/AIDS
4. Cost-effectiveness of STI Treatment for Preventing HIV/AIDS
5. Cost-effectiveness of Antiretroviral Therapy for Preventing Mother-to-Child Transmission of HIV
6. Cost-effectiveness of Harm Reduction for Injecting Drug Users for HIV Prevention

Chapter 60. Occupational Health

1. Estimated Average Cost-Effectiveness of Interventions for Reducing Risk of Silicosis

Chapter 12. Financing Health Systems in the 21st Century

1. Achieving Universal Health Coverage in Middle-Income Countries
2. Achieving Universal Health Coverage in Middle-Income Countries
3. Average Central Government Revenues, Early 2000s
4. Health Care Financing System Trends, by Country Income Level
5. Composition of Health Financing, by Country Income Level, 2001

Chapter 30. Diabetes: The Pandemic and Potential Solutions

1. Cost-effectiveness of Interventions for Preventing and Treating Diabetes in Developing Countries
2. Cost-effectiveness of Interventions for Preventing and Treating Diabetes in Developing Countries
3. Estimated Direct Medical Costs of Diabetes, By Region, 2003

Chapter 10. Gender Differentials in Health

1. Cost-effectiveness of Selected Interventions for Maternal Conditions
2. Cost-effectiveness of Selected Interventions for Chlamydia Infection
3. Cost-effectiveness of Selected Interventions for Cervical Cancer

Chapter 26. Maternal and Perinatal Conditions

1. Cost-effectiveness of Interventions for Maternal and Perinatal Conditions

Chapter 21. Conquering Malaria

1. Cost-effectiveness of Selected Malaria Interventions

Chapter 33. Cardiovascular Disease

1. Cost-effectiveness of Medical Therapy for Coronary Heart Disease, By Region
2. Cost-effectiveness of Medical Therapy for Heart Attacks, By Region

Chapter 27. Newborn Survival

1. Cost of Adding Newborn Care Packages to Maternal and Child Health Services

Chapter 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight

1. Cost-effectiveness of Interventions for Cardiovascular Disease in Latin America and the Caribbean*
2. Cost-effectiveness of Interventions for Cardiovascular Disease in Africa*
3. Cost-effectiveness of Interventions for Cardiovascular Disease in Southeast Asia*
4. Cost-effectiveness of Interventions for Cardiovascular Disease in the Western Pacific*
5. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease, By Region
6. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease in India

Chapter 68. Emergency Medical Services

1. Estimated Cost-effectiveness of Combined Use of Trained Lay First Responders and Paramedics
2. Estimated Cost-effectiveness of Staffed Community Ambulances in Urban Areas
3. Estimated Cost-effectiveness of Staffed Community Ambulances in Rural Areas

Chapter 31. Mental Disorders

1. Costs of a Mental Health Care Package, By Region

Chapter 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes

1. Incremental Cost-effectiveness of Reducing Salt Content by Legislation and Public Education
2. Incremental Cost-effectiveness of Reducing Saturated Fat Content
3. Incremental Cost-effectiveness of Reducing Trans Fat

Chapter 28. Stunting, Wasting, and Micronutrient Deficiency Disorders

1. Cost-effectiveness of Nutrition Interventions for Underweight Children
2. Cost-effectiveness of Nutrition Interventions for Vitamin A Deficiency in Children
3. Cost-effectiveness of Nutrition Interventions for Iron, Iodine, and Zinc Deficiency in Children

Chapter 39. Unintentional Injuries

1. Estimated Cost-effectiveness of Interventions Enforcing Traffic Regulations
2. Estimated Cost-effectiveness of Installing Speed Bumps at Lethal Intersections

Chapter 59. Adolescent Health Programs

1. Estimated Cost and Cost-effectiveness of Selected Adolescent Health Programs

Chapter 47. Alcohol

1. Estimated Cost-effectiveness of Interventions to Reduce High-Risk Drinking in Europe and Central Asia, Latin America and the Caribbean, and Sub-Saharan Africa
2. Estimated Cost-effectiveness of Interventions to Reduce High-Risk Drinking in East Asia and the Pacific and South Asia

Chapter 41. Water Supply, Sanitation, and Hygiene Promotion

1. Median Construction Cost of Water Supply Facilities for Select Regions
2. Median Construction Cost of Sanitation Technologies in Select Regions
3. Cost-effectiveness of Water Supply, Sanitation, and Hygiene Promotion

Chapter 57. Contraception

1. Average Cost of Family Planning Services per Infant and Maternal Death Averted
2. Average Cost of Family Planning Services per Birth Averted and per DALY Averted